Screening of Maternal Serum for Fetal Down's Syndrome in the First Trimester
1998; Massachusetts Medical Society; Volume: 338; Issue: 14 Linguagem: Inglês
10.1056/nejm199804023381404
ISSN1533-4406
AutoresJames E. Haddow, Glenn E. Palomaki, George J. Knight, Josephine Williams, Wayne A. Miller, Anthony Johnson,
Tópico(s)Parvovirus B19 Infection Studies
ResumoScreening of maternal serum to identify fetuses with Down's syndrome is now routinely offered during the second trimester of pregnancy. Prenatal screening by means of serum assays or ultrasonographic measurements, either alone or in combination, may also be possible in the first trimester.
Referência(s)